Acologix Inc., of Emeryville, Calif., appointed David Rosen vice president, research and development, mineral metabolism projects.

Adenosine Therapeutics LLC, of Charlottesville, Va., appointed Michael Williams to its board.

Affitech AS, of Oslo, Norway, named Martin Welschof chief operating officer, Atle Steinsland chief financial officer and Bjorn Cochlovius director of preclinical development.

Allos Therapeutics Inc., of Westminster, Colo., appointed David DeLong vice president, sales and marketing.

Amarin Corp., of London, appointed Stefan Ohlsson managing director of Amarin Development AB in Malmo, Sweden.

AtheroGenics Inc., of Atlanta, appointed Robert Scott senior vice president of clinical development and regulatory affairs.

Atrix Laboratories Inc., of Fort Collins, Colo., promoted Eric Dadey to director of drug delivery.

Barrier Therapeutics Inc., of Princeton, N.J., appointed Charles Nomides chief operating officer.

Blackstone Computing, of Worcester, Mass., said Michael Savage joined the company as chairman.

Cerylid Biosciences Ltd., of Melbourne, Australia, appointed J.J. Kim Wright to its scientific advisory board.

Emergent Technologies Inc., of Austin, Texas, named Paul Dlabal to chair its new clinical advisory board.

Essential Therapeutics Inc., of Waltham, Mass., appointed Timothy Noyes chief operating officer.

GeneLink Inc., of Margate, N.J., added Robert Schwarzberg as a medical consultant.

Illinois Biotechnology Industry Organization, of Chicago, appointed David Miller president.

Insmed Inc., of Richmond, Va., appointed Lewis Stuart vice president of commercial development.

LaunchCyte LLC, of Pittsburgh, appointed Robert Johnston to its board.

Lexicon Genetics Inc., of The Woodlands, Texas, promoted Brian Zambrowicz to executive vice president of research.

Neose Technologies Inc., of Horsham, Pa., appointed Robert Kriebel senior vice president and chief financial officer. Also, it promoted Brian Davis to vice president, finance; Debra Poul to vice president and general counsel; and Marjorie Hurley to vice president, regulatory affairs and project management.

Norak Biosciences Inc., of Research Triangle Park, N.C., appointed Peter Heath vice president, finance and chief financial officer.

NuGEN Technologies Inc., of San Carlos, Calif., appointed Elena Grigorenko to its advisory board.

Prana Biotechnology Ltd., of Melbourne, Australia, appointed Dianne Angus vice president of intellectual property and licensing.

Predix Pharmaceuticals Inc., of Woburn, Mass., appointed Dale Dhanoa senior vice president of research and discovery.

U.S. Genomics, of Woburn, Mass., added Craig Venter to its board and he also is a scientific adviser.

United Therapeutics Corp., of Silver Spring, Md., appointed Michael Joseph to its board and he will serve as chairman of the audit committee.

XenoPort Inc., of Santa Clara, Calif., appointed Daniel Canafax as its vice president of clinical development.